UBE2D1 Antibody - middle region : FITC (ARP43006_T100-FITC)

The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. UBE2D1 is a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is closely related to a stimulator of iron transport (SFT), and is up-regulated in hereditary hemochromatosis. It also functions in the ubiquitination of the tumor-suppressor protein p53 and the hypoxia-inducible transcription factor HIF1alpha by interacting with the E1 ubiquitin-activating enzyme and the E3 ubiquitin-protein ligases.

RBX1; STUB1; RNF7; RNF14; MID1; MDM2; EP300; CREBBP; ANAPC11; DTL; RNF115; MKRN2; NEDD4L; FAF2; TRIM32; MID2; RNF111; RNF5; RSP5; GPB1; NHLRC1; RFFL; UHRF2; DTX2; ZNRF1; TRIM63; RNF146; FBXO31; RNF26; TRIM39; RNF126; FBXW7; NEDD4; CUL1; CUL3; MKRN3; UBE3A

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.